SPRYCEL (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the SPRYCEL drug offered from E.R. Squibb & Sons, L.L.C.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | dasatinib |
| SUBSTANCE NAME: | DASATINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-06-27 |
| END MARKETING DATE: | 0000-00-00 |
SPRYCEL HUMAN PRESCRIPTION DRUG Details:
| Item Description | SPRYCEL from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 70(mg/1) |
| START MARKETING DATE: | 2006-06-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-0524_f0719d03-ac55-413a-aea2-677a5cde1ff3 |
| PRODUCT NDC: | 0003-0524 |
| APPLICATION NUMBER: | NDA021986 |
Other DASATINIB Pharmaceutical Manufacturers / Labelers:
